The retinoic acid receptor-related orphan receptors D and J (RORD and RORJ), are key regulators of helper T (Th)17 cell differentiation, which is involved in the innate immune system and autoimmune disorders. However, it remains unclear whether environmental chemicals, including pesticides, have agonistic and/or antagonistic activity against RORD/J. In this study, we investigated the RORD/J activity of several azole-type fungicides, and the effects of these fungicides on the gene expression of 
Introduction
T helper (Th) cells with diverse effector functions differentiate from naïve CD4 + T cells upon stimulation by antigens in the presence of various cytokines produced by cells of the innate immune system. Th17 cells, the T helper cells that produce interleukin 17 (IL-17) and other pro-inflammatory cytokines, were recently identified as a novel Th subset and play important roles in host defense against bacterial and fungal infections, and in a wide variety of autoimmune disease, including psoriasis and rheumatoid arthritis (Harrington et al., 2005; Park et al., 2005; Weaver et al., 2007; Stockinger and Veldhoen, 2007) . In Th17 cells, the transcription of IL-17 is mediated by Th17-specific transcriptional regulators of the retinoic acid receptor-related orphan receptors, RORD and RORJ (Ivanov et al., 2006; Yang et al., 2008) .
RORD/J are members of the nuclear hormone receptor superfamily, which contains a signature type II zinc finger DNA binding motif and a hydrophobic ligand binding pocket (Jetten et al., 2001) . To date, three subtypes, designated RORD, -E, and -J (NR1F1-3 or RORA-C), have been identified with distinct tissue distributions and biological activities (Jetten, 2009 ). In the thymus, RORD and two isoforms, J1 and J2
(also named RORJt), have been identified (He et al., 1998) , with RORJt differing from the RORJ1 isoform in that it lacks the amino terminus of RORJ1. The RORs bind as monomers to ROR response elements (ROREs) in the promoter regulatory region of the target genes (Giguere et al., 1994; Medvedev et al., 1996) . Recent studies have also demonstrated that RORs function as ligand-dependent transcriptional factors. For 5 example, in some cholesterol metabolites, 7D-hydroxycholesterol was reported to be a RORD and RORJ inverse agonist that inhibits the basal transcription mediated by RORD D and RORJ, respectively (Wang et al., 2010a) , while cholesterol sulfate was reported to function as an RORD agonist (Kallen et al., 2004) . In addition, Kumar et al. (2010) provided novel evidence that N-(2,2,2-trifluoroethyl)-N-[4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl-ethyl)-pheny l]-benzene sulfonamide (T0901317), known to be a potent agonist of liver X receptor (LXR, NR1H1-3), was reported to be an inverse agonists of RORD and RORJ. In fact,
other previous studies had shown that this compound leads to a decreased severity of experimental autoimmune encephalomyelitis (EAE), which is dependent on Th17 cell function (Hindinger et al., 2006; Xu et al., 2009) . Recent novel studies have also provided evidences that a synthetic chemical SR1001, digoxin derivatives, and ursolic acid act as ROR inverse agonists and ameliorate EAE disease in mice (Solt et al., 2011; Huh et al., 2011; Xu et al., 2011) . As Th17 cells play an important role in both the immune response to invading pathogens and autoimmunity (Harrington et al., 2005; Park et al., 2005) , the identification of ROR modulators, such as ROR agonists and inverse agonists, would be of great value with regard to immunotoxicity against the innate immune system and drug-therapy for autoimmune diseases. However, although exposure to environmental agents can compromise a number of immunological functions, the effects of environmental chemicals against RORs remain unclear.
Pesticides are used globally to control agricultural and indoor pests, and are 6 intentionally released into the environment in large quantities. As pesticides possess a wide variety of chemical structures, they may represent the most likely candidates for ligands against nuclear receptors (Kojima et al., 2010) . Transactivation or reporter gene assays, a powerful tool for testing receptor agonists and antagonists among chemicals, have been established as an in vitro method for evaluating the receptor activity of chemicals. We previously developed novel highly sensitive reporter gene assays using
Chinese hamster ovary (CHO) cells for detecting human estrogen receptor (ER)D, ERE and androgen receptor (AR) activities among numerous chemicals (Kojima et al., 2003; , and demonstrated that a number of environmental chemicals, including pesticides, possess ERD-and ERE-mediated estrogenic activities and/or AR-mediated antiandrogenic activity (Kojima et al., 2004; 2009; Takeuchi et al., 2005; 2009; .
We have now performed a pesticide screen of around 200 compounds using CHO cell-based RORD/J reporter gene assays, and identified several pesticides possessing RORD/J activity. In the present study, we show that five azole-type fungicides have RORD and/or RORJ inverse agonistic activity. In addition, we examined whether these fungicides affect IL-17 gene expression in mouse T lymphoma EL4 cells, and found that these fungicides suppress IL-17 mRNA expression. Here, we provide the first evidence that environmental chemicals might affect IL-17 gene transcriptional activity via RORD and/or RORJ.
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Materials and Methods
Chemicals. Hexaconazole (>99% pure) and imazalil (>98% pure) were purchased from Wako Pure Chemical Industries Ltd. (Wako; Osaka, Japan). Imibenconazole (>99% pure) and triflumizole (>99% pure) were purchased from Kanto Chemical Company Ltd.
(Tokyo, Japan Plasmids. We used the expression plasmids pCMV10-mRORD4 and pCMV10.RORJ1
encoding the full-length receptor protein and the reporter plasmid pGL4.27(RORE)5-Luc (pRORE-Luc) for determining RORD/J activity (Takeda, Y., unpublished). We used the expression plasmids pTARGET-hLXRD and pTARGET-hLXRE and fusion protein expression plasmids hLXR-N/pBIND and hLXR-C/pACT for determining LXRD/E activity (Kobayashi et al., 2010 with a 5-Pl aliquot of the cell lysate using the Luciferase Assay System (Promega), according to the manufacturer's instructions. We measured E-galactosidase activity to check the cytotoxicity of the test compounds against transcriptional activity using a fluorescence method as described previously (Takeuchi et al., 2005; . The luciferase activity was normalized against the E-galactosidase activity for each treatment. Results are expressed as mean r SD from at least three independent experiments performed in triplicate.
To estimate the potency of the receptor-inverse agonistic activity of the compounds tested, the concentration of the compound exhibiting a response equal to 20% that of the vehicle control response was evaluated from a dose-response curve of the luminescence intensity, and expressed as the 20% relative inhibitory concentration (RIC 20 ).
Reporter gene assays for LXRD and LXRE. The LXRD and LXRE assays were performed using the same procedure as that for the RORD/J assays. Namely, COS-7 cells were transfected with 50 ng of either pTAGET-hLXRD or pTARGET-hLXRE, 50
ng hLXR-N/pBIND, 50 ng hLXR-C/pACT, and 10ng pCMV-EGal per well using the FuGene6 transfection reagent. The LXR agonist, T0901317, was utilized as a positive control in these LXRD/E assays.
EL4 cells experiments, isolation of RNA and reverse transcription.
We plated the host EL4 cells in 12-well microtiter plates (Nalge, Nunc, Denmark) at a density of 2 × 10 6 cells/ml in RPMI-1640 medium containing 10% FBS. Next day, EL4 cells were treated with vehicle or both PMA (5 ng/ml) and ionomycin (1 PM) for induction of IL-17.
Simultaneously, the cells were treated with vehicle, 1, 3, 10 or 30 PM of the fungicides or 0.1-10 PM T0901317 as a ROR inverse agonist (positive control), and incubated at 37 for 6 h. The EL4 cells were removed, rinsed with isotonic saline, and homogenized in TRIzol Reagent (Molecular Research Center, Cincinnati, OH, USA).
Total RNA was isolated from the EL4 cells using TRIzol Reagent (1 mL/100 mg of tissue) following the manufacturer's instructions. The complementary DNA (cDNA) was synthesized using 5 Pg of total RNA by Revertra Ace reverse transcriptase (TOYOBO, Osaka, Japan). The cDNAs were then stored at -20 until analysis.
Reverse transcription polymerase chain reaction (RT-PCR).
The following primers were synthesized: for IL-17A, 5'-TCCAGAAGGCCCTCAGACTA-3' and 5'-AGCATCTTCTCGACCCTGAA-3'; and for E-actin, 5'-TGTTACCAACTGGGACGACA-3' and 5'-GGGGTGTTGAAGGTCTCAAA-3'.
PCR amplification was conducted on cDNA (20 PL) synthesized from 0. and Rorc (5'-GCTACCAGAGGAAGTCAATGT-3'), and subsequent selection in G418-containing medium.
Similarly, a control shRNA (nonsilencing;
5'-TTCTCCGAACGTGTCACGT-3')-transfected EL4 cell line (EL4/shNC) was also established.
Data analysis.
We used an analysis of variance (ANOVA) followed by Bonferroni correction to evaluate the differences in transcriptional levels between the control group and each of the chemical groups in the reporter gene assays and quantitative RT-PCR assays. Statistical significance was set at p < 0.05. Data were presented as means ± SD of three triplicate experiments.
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Results
Effects of azole-type fungicides on transcriptional activity in the RORD and RORJ
assays. Figure 1 shows the chemical structures of T0901317 and five azole-type fungicides tested in this study. We examined the effects of these compounds on RORD-and RORJ-mediated transcriptional activity using CHO cell-based reporter gene assays. As a result, T0901317 and five azole-type fungicides didn't show any RORD/J agonistic activity. However, we found that these compounds have RORD and/or RORJ inverse agonistic activity, which inhibits their constitutive activation. Figures 2A and B show the inhibitory effects of five azole-type fungicides together with T0901317 on transcriptional activity via RORD and RORJ, respectively. In the RORD assay, although imazalil and tetraconazole did not show almost any inverse agonistic activity, imibenconazole, triflumizole and hexaconazole were found to be weak RORD inverse agonists similar to T0901317 ( Fig. 2A) . However, in the RORJ assay, these five fungicides and T0901317 showed inverse agonistic activity in a dose-dependent manner from 1 to 30 PM (Fig. 2B) . The order of relative potency for RORJ inverse agonistic activity were T0901317 > Imibenconazole > triflumizole, hexaconazole > tetraconazole, Imazalil. Based on their E-galactosidase activity, none of the compounds tested in this study showed any cytotoxic effects, except for the highest dose (30 PM) of T0901317 and imibenconazole. From these dose-response curves, we estimated the RIC 20 values of five azole-type fungicides and T0901317 for RORD and RORJ, and summarized in Table 1 .
Effects of azole-type fungicides in the LXRD/E transactivation assays.
As T0901317 is a potent LXR agonist, we investigated whether the five azole-type fungicides also possess LXR agonistic activity similar to T0901317. Figures 3A and B show LXRD-and LXRE-mediated transactivation by the fungicides and T0901317.
Although T0901317, as expected, induced LXRD and LXRE activation at low concentrations of 10 -7 M order, none of the five fungicides showed any LXRD or LXRE agonistic activity even at a high dose of 1 × 10 -5 M.
Effects of T0901317 on in vitro expression of IL-17A mRNA in mouse T lymphoma EL4
cells.
Since induction of IL-17A via ROR is a specific positive marker in Th17 cell proliferation pathway, we examined whether azole-type fungicides affect IL-17A level in EL4 cells. Figure 4 shows the inhibitory effect of T0901317 on IL-17A gene expression in PMA/ionomycin-stimulated EL4 cells. Although neither T0901317 nor the vehicle induced the expression of IL-17A gene in non-stimulated EL4 cells, T0901317 inhibited IL-17A mRNA expression in a dose-dependent manner in PMA/ionomycin-stimulated EL4 cells (Fig. 4A) . Real-time PCR analysis revealed that T0901317 significantly inhibited IL-17A mRNA expression at concentrations of 0.1, 1, and 10 PM, although it did not affect RORD and RORJ mRNA expressions (Fig. 4B ). (Figs. 5A and C) . On the other hand, these fungicides failed to affect the expression levels of RORD and of RORJ mRNAs ( Fig. 5A-E) .
Effect of Imibenconazole and T0901317 on IL-17A mRNA expression in the RORD/J knockdown EL4 cells.
We established EL4/shRorac and EL4/shNC cells as endogenous RORD and RORJ double-knockdown EL4 and control EL4 cell lines, respectively, using shRNA 
Discussion
Unlike steroid hormone receptors, apo-RORD and -J are constitutively active and retain the ability to interact with a range of coactivator NR box peptides in the absence of binding to any ligand (Jetten et al., 2001) . In fact, RORs are orphan receptors whose endogenous ligands are still unclear. However, recent studies have reported that the binding of cholesterol metabolites (e.g., 7-oxygenated sterols) to RORD/J reduces the level of this constitutive interaction, resulting in the repression of the transcriptional output of the receptors (Wang et al., 2010a) . In addition, Kumar et al. (2010) provided evidence that the synthetic chemical T0901317, which is also a potent LXR agonist, directly binds to RORD and RORJ with high affinity (Ki = 132 and 51 nM, respectively), and represses RORD/J-dependent transactivation of RORE reporter genes.
Therefore, these cholesterol metabolites and T0901317 are classified as ROR inverse agonists that inhibit ROR basal transcriptional activity in the absence of agonist, and are distinct from ROR antagonists that themselves do not effect the receptor equilibrium but are capable of competitive antagonism of both agonists and inverse agonists (Klein et al., 1996) . In this study using CHO-K1 cell-based reporter gene assays, we found that T0901317 decreased RORD-and RORJ-dependent luciferase induction at a RIC 20 of 12 PM and 0.97 PM, respectively (Table 1) , thereby supporting the results obtained by Kumar et al. (2010) . More recently, they have reported that synthetic compounds derived from the benzenesulfonamide scaffold, SR1078 and SR1001, act as a RORD/J agonist and RORD/J inverse agonist, respectively (Wang et al., 2010b; Solt et al., 2011) . This suggested the possibility that small molecule compounds, such as environmental chemicals, may also act as ligands of ROR.
We investigated the potential agonistic and inverse agonistic activity of about 200 pesticides against RORD and RORJ using CHO-K1 cell-based reporter gene assays. As a result, we have found that five azole-type fungicides inhibited constitutive activation of RORD and RORJ in a dose-dependent manner similar to T0901317 (Fig. 2) . In particular, imibenconazole, triflumizole and hexaconazole were found to inhibit basal RORJ-mediated transactivation at concentrations of 10 -6 M order. According to a recent study by Martin et al. (2010) , hexaconazole has been listed as a potent ROR inhibitor together with other 13 pesticides, supporting our results. As shown in Fig. 1 , five fungicides acting as ROR inverse agonists have structures similar to each other and resembling T0901317, although the RORD/J activities of these fungicides were weaker than those of T0901317.
It is topical that, in recent immunological studies, a novel Th subset, termed Th17, which preferentially produces IL-17, has been identified as a distinct Th lineage mediating tissue inflammation (McGeachy and Cua, 2008) . Th17 cells are defined by their secretion of the pro-inflammatory cytokine IL-17, which mediates the recruitment of inflammatory cells and the induction of pro-inflammatory mediators by endothelial cells (Ouyang et al., 2008) . Therefore, Th17 cells and their effector cytokines mediate the host defense mechanisms to various infections, especially extracellular bacteria infections, and are involved in the pathogenesis of many autoimmune diseases (Ouyang et al., 2008; Stockinger and Veldhoen, 2007) . Several mechanism studies have revealed that RORD and RORJ, and particularly the RORJt isoform, act as Th17 lineage-specific master transcription factors (Ivanov et al., 2006; Yang et al., 2008) . For example, Yang et al. (2008) demonstrated that RORD and RORJ co-expression synergistically leads to greater IL-17 production in Th17 cells, whereas double deficiencies in RORD and RORJ globally impair IL-17 production and completely protect mice against EAE. Thus, it is important to investigate whether chemicals having ROR activity affect Th17 differentiation, and to identify ROR agonists and antagonists. In this study, we A synthetic compound, T0901317, is well known as a potent LXR agonist.
T0901317 has been reported to suppress Th17 function in a mouse autoimmune model of EAE (Xu et al., 2009) , supporting our results regarding the inhibition of IL-17 expression by T0901317. However, Cui et al. (2011) have recently reported that the LXR agonistic activity of T0901317 is involved in the repression of IL-17 production, 20 and leads to EAE prevention. Therefore, we examined whether these fungicides show LXR agonistic activity, and confirmed that they did not act as LXR agonists (Fig. 3) .
This suggests that the five fungicides affect IL-17 gene expression via ROR, not LXR, unlike T0901317, a potent LXR agonist. Thus, our findings indicate that environmental chemicals, such as pesticides, may act as regulatory molecules of Th17 cell function as ROR inverse agonists, leading to potential effects on the immune system in whole organisms.
The EL4 cells constitutively express RORD (encorded by Rora), RORJ (Rorc) and IL-17A (Il17a) (Ichiyama et al., 2008) . Next, we established the RORD/J knockdown EL4 (EL4/shRorac) cells using shRNA technology. As a result, we found that IL-17A mRNA expression was clearly suppressed in EL4/shRorac cells when they were treated with PMA/ionomycin. This suggests that RORD/J is a critical regulator of IL-17 gene expression in EL4 cells, as pointed out by other studies (Ichiyama et al., 2008; Solt et al., 2011) . More importantly, although treatment of EL4/shNC cells with imibenconazole and T0901317 potently suppressed IL-17A mRNA expression, treatment of EL4/shRorc cells with those also resulted in decrease. This may suggest that the remained RORD/J are involved in suppression of IL-17A mRNA expression by imibenconazole and T0901317.
Azole fungicides are widely used in agriculture and in human mycosis (Zarn et al., 2003; Giavini and Menegola, 2010) . Their antifungal activity is based on their ability to inhibit fungal CYP51 (lanosterol 14D-demethylase), a key enzyme in the formation of 21 the fungal wall. In addition, several azoles are also used in antiestrogen therapy such as in breast cancer treatment, as they inhibit CYP19 (aromatase), a key enzyme in the estrogen biosynthesis (Zarn et al., 2003) . Although five azole-type fungicides showed ROR inverse agonistic activity, triazole or imidazole structures, which play an important role in antifungal activity, might be not necessary for ROR activity as other azole fungicides (bitertanol, triadimefon, propiconazole, and prochloraz) were inactive (data not shown). Thus, further studies on the structural property of azole-type fungicides are required for elucidating their ROR inverse agonistic activity.
The present study also indicates the structural design of potent and selective ROR ligands with potential application in the treatment of metabolic and immune disorders (Kumar et al., 2010; Solt et al., 2010) . has been reported to be an agonist of RORD and RORJ (Wang et al., 2010b) . Thus, in addition to identifying ROR inverse agonists, the study for identifying ROR agonists among numerous environmental chemicals is also required to prevent the acceleration of immune inflammation by environmental factors. Simultaneously, the cells were treated with 0.1% DMSO (vehicle control), 0.1, 1, or 10
PM of T0901317 at 37˚C for 6 h. IL-17A and E-actin mRNA expressions were amplified by qualitative RT-PCR using specific primers, and amplified products (5 PL)
were separated by electrophoresis on 1.5% agarose gels and stained with ethidium 
